Bioequivalence study of Atenolol: Pharmacokinetic and pharmacodynamic evaluation

Daru

Volumn 11, Issue 3, 2003, Pages 95-98

  Mirfazaelian, Ahmad ^a   Tabatabaeifar, Mahmoud ^b   Rezaee, Saeed ^a   Mahmoudian, Massoud ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atenolol; Blood pressure; Heart rate; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD PRESSURE; BLOOD SAMPLING; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; PHARMACODYNAMICS; TABLET FORMULATION;

EID: 0345743696     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. th. edition, Mc Graw-Hill, pp 238
2. Fitzgerald, J.D., Ruffin, R., Smedstad, K.G., Roberts, R., McAinsh, J. (1987) Studies on the pharmacokinetics and pharmacodynamics of atenolol in man. Eur. J. Clin. Pharmacol. 13:81-89.
3. Conway, F.J., Fitzgerald, J.D., McAinsh, J., Rowlands, D.J., Simpson, W.T. (1976) Human pharmacokinetics and pharmacodynamic studies on atenolol (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug. Brit. J. Clin. Pharmacol. 3:267-272
4. Marlin, G.E., Kumana, C.R., Kaye, C.M., Smith, D.M., Turner, P. (1975) An investigation into the cardiac and pulmonary beta adrenoceptor activity of ICI 66,082 in man. Brit. J. Clin. Pharmacol. 2:151-157
5. Brown, H.C., Carruthers, S.G., Johunson, G.D., Kelly, J.G., McAinsh, J., McDevitt, D.G., Shands, R.G. (1976) Clinical pharmacological observations on atenolol, a beta adrenoceptor blocker. Clin. Pharmacol. Ther. 20:524-534
6. Lefebvre, M.A., Girault, J., Fourtillan, J.B. (1981) β-Blocking agents: Determination of biological levels using H.P.L.C., J. Liquid Chromatogr. 4:483-500.
7. th Iranian Cong. Physiol. Pharmacol. Paper P3-18
8. Kunka, R.L., Wong, Y.Y., Anderson, R.L., Haack, D.G. (1989) Steady-state fluctuation and variability of betaxolol and atenolol plasma levels. Therap. Drug Monit. 11:523-527
9. Wadworth, A.N., Murdoch, D., Brogden, R.N. (1991) Atenolol: a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders, Drugs 42:468-510
10. McAinsh, J., Simpson, W.T., Holmes, B.F., Yang, J., Ellis, S.H. (1980) Bioavalability of atenolol formulations, Biopharm. and Drug Disp. 1:323-332.
11. Wilcox, R.G., Bennet, T., MacDonald, I.A., Herbert, M., Skene, A.M. (1984) The effects of acute or chronic ingestion of propranolol of metoprolol on the physiological responses to-prolonged submaximal exercise in hypertensive men. Br. J. Clin. Pharmac. 17:273-281.
12. Wilcox, R.G., Bennet, T., MacDonald, I.A., Pipkin, F.B., Baylis, P.H. (1987) Post exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men. Br. J. Clin. Pharmac. 24:151-162.
13. Somers, V.K., Conway, J., Lewinter, J., Sleight, P. (1985) The role of baroreflex sensitivity in post exercise hypotension. J. Hypertension 3:S129-S130.
14. Floras, J.S., Aylward, P.E., Sinkey, C., Mark, A.L. (1986) Post exercise decreases in blood pressure are accompanied by decreases in muscle sympathetic nerve activity. Clin. Res. 34: 780A.
15. Nelson, L., Jennings, G.L., Esler, M.D., Korner, P.I. (1986) Effect of changing levels of physical activity on blood pressure and haemodynamics in essential hypertension. Lancet, ii:473-476.